Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
NCT01239069
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
140
Enrollment
INDUSTRY
Sponsor class
Conditions
Dry Eye
Interventions
DRUG:
DE-110 ophthalmic suspension high dose
DRUG:
DE-110 ophthalmic suspension low dose
OTHER:
Placebo
Sponsor
Santen Inc.